๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Nephrogenic fibrosing dermopathy: A rare entity in patients awaiting liver transplantation

โœ Scribed by Henry Chiu; Gregory Wells; Henry Carag; Erica Canova; Roberto J. Firpi


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
182 KB
Volume
10
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

โœฆ Synopsis


A 56-year-old Caucasian female with end-stage liver disease secondary to โฃ1-antitrypsin deficiency and end-stage renal disease secondary to idiopathic membranous nephropathy presented with a one-week history of increased bilateral lower extremity edema and anasarca. On admission, the patient complained of raised hardened areas especially prominent on the upper medial thighs that were painful, warm, and nonpruritic. She denied any constitutional symptoms and denied using any new medications. On exam, the patient was found to be afebrile with stable oxygen saturation. The abdomen was distended with evidence of hepatomegaly. Bilateral lower extremity edema to the groin were present, and hyperpigmented plaques (Fig. 1) (tender, indurated, and warm) were noted on the upper medial aspects of her thighs, but not involving the groin. There was no visible face or upper extremity involvement.

Laboratory tests did not reveal leukocytosis or eosino-


๐Ÿ“œ SIMILAR VOLUMES


Serum ferritin concentration predicts mo
โœ Nicole M. Walker; Katherine A. Stuart; Rebecca J. Ryan; Shireena Desai; Sammy Sa ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 216 KB ๐Ÿ‘ 1 views

Additional markers are required to identify patients on the orthotopic liver transplant (OLT) waiting list at increased risk of death and adverse clinical events. Serum ferritin concentration is a marker of varied pathophysiological events and is elevated with increased liver iron concentration, hep

A randomized, controlled study of treatm
โœ Robert M. Weinrieb; Deborah H.A. Van Horn; Kevin G. Lynch; Michael R. Lucey ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 124 KB

Alcohol is the second most common cause of cirrhosis necessitating liver transplantation in the United States, yet rates of posttransplant drinking approach 50% and no controlled clinical trials of alcoholism treatment exist in this population. Eligible patients were randomly assigned to receive Mot

Hepatocellular carcinoma in HCV-infected
โœ Valeria R. Mas; Daniel G. Maluf; Richard Stravitz; Catherine I. Dumur; Bradly Cl ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 513 KB

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading cause of cancer death in the world. The present study aimed to investigate the genes involved in viral carcinogenesis and tumor progression in liver transplant recipients with hepatitis C virus (HCV) and HCC. To acc

Use of sorafenib in patients with hepato
โœ Alessandro Vitale; Michael L. Volk; Davide Pastorelli; Sara Lonardi; Fabio Farin ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 361 KB ๐Ÿ‘ 1 views

The role of bridging therapies for patients with hepatocellular carcinoma (HCC) on the waiting list for liver transplantation (LT) remains controversial. There is strong evidence to support the effectiveness of sorafenib in extending the time to progression of HCC. Using a Markov model, we compared

Cruveilhier-Baumgarten disease in a pati
โœ Federico Aucejo; Zuhaib Ibrahim; Koji Hashimoto; Cristiano Quintini; Dympna Kell ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 419 KB

Some chromosomal alterations can be associated with vascular abnormalities. For instance, Turner syndrome can be complicated by agenesis or hypoplasia of the portal venous system causing presinusoidal portal hypertension. Liver transplantation to treat this condition overcomes portal hypertension an